article thumbnail

J&J's patient assistance program suffers data breach, IBM says

Fierce Pharma

IBM disclosed "unauthorized access" to J&J’s Janssen CarePath patient assistance program, which helped over 1 million U.S. patients last year.

Patients 330
article thumbnail

GSK’s long-acting HIV med Cabenuva beats daily therapy in patients who've faced adherence hurdles

Fierce Pharma

GSK’s long-acting HIV regimen Cabenuva has already shown it works as well as daily oral therapies in patients who have the virus under control. GSK’s long-acting HIV regimen Cabenuva has already shown it works as well as daily oral therapies in patients who have the virus under control.

Patients 205
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Providing a Pathway to Patient Connectivity and Adherence

Fierce Pharma

Today, gaining consistent access to life-saving medications can be a significant hurdle that many patients must learn to navigate. Specialty therapy patients require accessible prescription management solutions that can simplify communication, improve access, and increase adherence.

Patients 169
article thumbnail

Merck's Keytruda extends life for kidney cancer patients after surgery, while Bristol's Opdivo fails again

Fierce Pharma

This comes just as the drug’s rival, Bristol Myers Squibb’s Odpivo, chalked up another trial failure.

Patients 322
article thumbnail

Making the Case for Case Management for Cell and Gene Therapies

Deviations from the intended supply chain can delay timelines and affect these high value products, which can be detrimental to budgets, but more importantly can have dire effects on the patients whose lives depend on receiving these critical doses safely and on time.

article thumbnail

Sculpting Seamless Patient Experiences: Five hallmarks of a highly effective patient support program

Fierce Pharma

Unlock the art of sculpting seamless patient experiences with these five hallmarks of highly effective patient support programs. Treatment journeys — especially those involving specialty medications — can be complex and arduous.

Patients 161
article thumbnail

J&J, IBM face class-action lawsuit over patient data breach

Fierce Pharma

As if the talc product liability lawsuits weren’t enough headache for Johnson & Johnson, the New Jersey pharma is now facing another lawsuit from patients, this time about a recent data breach. |

Patients 261
article thumbnail

Running Decentralized Trials at Scale: Planning for Success

The potential for reaching a larger pool of recruits is possible when sponsors can bring more trial activities to the patient. There’s been a rapid shift towards decentralization in clinical trials & it’s clear why.

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. Clinical trial data management is increasingly challenging as studies grow in complexity. In this paper, we explore real-time data access and analysis for proactive study management.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

Learning Objectives: Dose-response curves and patient treatment: How do pharmacologic and toxicologic principles apply to the dosing of drugs in clinical development? Ben Locwin will discuss the potential effects of this draft, along with the pharmacological and toxicological considerations for optimizing doses of prescription drugs.